Literature DB >> 9291912

Tacrolimus-induced bone marrow suppression.

C de-la-Serna-Higuera, R Bárcena Marugán, J Avilés, J Nuño, A Cantalapiedra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9291912     DOI： 10.1016/s0140-6736(05)63514-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.

Authors:  Annamaria Nosari; Laura Marbello; Luciano G De Carlis; Andrea De Gasperi; Giuliana Muti; Valentina Mancini; Enrica Morra
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

2.  Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis.

Authors:  Zhongbo Yang; Thomas Loew; Richard D Hammer
Journal:  Clin Case Rep       Date:  2015-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.